|
May 8
|
Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates
|
|
May 8
|
Halozyme to Participate in Upcoming Investor Conferences
|
|
May 8
|
Q1 2024 Halozyme Therapeutics Inc Earnings Call
|
|
May 8
|
Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
|
|
May 7
|
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 7
|
Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
|
|
May 7
|
Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
|
|
May 7
|
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
|
|
May 6
|
Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
|
May 3
|
How Novo-Catalent Deal Affects Halozyme (HALO)?
|
|
Apr 30
|
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
|
|
Apr 25
|
Mahesh Krishnan Elected to Halozyme's Board of Directors
|
|
Apr 25
|
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
|
|
Apr 23
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Apr 23
|
Halozyme to Report First Quarter 2024 Financial and Operating Results
|
|
Apr 18
|
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
|
|
Apr 18
|
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
|
|
Apr 5
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
Apr 4
|
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?
|
|
Apr 4
|
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?
|